Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded access aviptadil for severe COVID-19 respiratory failure
MOH_2020-11-03_009472Phase 3Recruiting
- Sponsor
- ד"ר יעל חביב
- Start
- Oct 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aviptadil in coronavirus disease 2019 (COVID-19), sponsored by ד"ר יעל חביב. Primary endpoint: Mortality. Started Oct 2020; status: recruiting.
02
Drugs
aviptadil
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2020-11-03_009472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-11-03_009472.